Human kallikrein 3 (prostate-specific antigen) and human kallikrein 5 expression in salivary gland tumors

International Journal of Biological Markers

Volumn 21, Issue 4, 2006, Pages 201-205

  Darling, Mark R ^a   Tsai, S ^b   Jackson Boeters, L ^a   Daley, T D ^a   Diamandis, E P ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Human kallikrein 3; Human kallikrein 5; Immunohistochemistry; Kallikreins; Prognostic markers; Salivary gland tumors

Indexed keywords

KALLIKREIN; KALLIKREIN 5; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER GRADING; CONTROLLED STUDY; EPITHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINIZATION; MAJOR CLINICAL STUDY; MINOR SALIVA GLAND; PLEOMORPHIC ADENOMA; PROTEIN EXPRESSION; SALIVARY GLAND CANCER; SALIVARY GLAND TUMOR; STAINING;

EID: 33846505601     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.2048     Document Type: Article

References (33)

1. Diamandis EP, Yousef GM, Luo LY, Magklara A, Obiezu CV. The human kallikrein gene family - implications in carcinogenesis. Trends Endocrinol Metab 2000; 11: 54-60.
2. Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: Structure, function and association to disease. Endocr Rev 2001; 22: 184-204.
3. Borgono CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2004; 2: 257-80.
4. Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004; 4: 876-90.
5. Yousef GM, Diamandis EP. Human tissue kallikreins: a new enzymatic cascade pathway? Biol Chem 2002; 383: 1045-57.
6. Diamandis EP, Yousef GM. Human tissue kallikreins: A family of new cancer biomarkers. Clin Chem 2002; 48: 1198-205.
7. Diamandis EP, Yousef GM. Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev Mol Diagn 2001; 1: 182-90.
8. Obiezu C, Diamandis E. Human tissue kallikrein family: applications in cancer. Cancer Lett 2005; 224: 1-22.
9. James GK, Pudek M, Berean KW, Diamandis EP, Archibald BL. Salivary duct carcinoma secreting prostate-specific antigen. Am J Clin Pathol 1996; 106: 242-7.
10. Barry MJ. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med 2001; 344: 1373-7.
11. Lundwall A. Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem Biophys Res Commun 1989; 161: 1151-9.
12. Olsson AY, Bjartell A, Lilja H, Lundwall A. Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues. Int J Cancer 2005; 113: 290-7.
13. Yousef GM, Diamandis EP. The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. J Biol Chem 1999; 274: 37511-6.
14. Michael IP, Pampalakis G, Mikolajczyk SD, Malm J, Sotiropoulou G, Diamandis EP. Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression. J Biol Chem 2006; 281: 12743-50.
15. Michael IP, Sotiropoulou G, Pampalakis G, et al. Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. J Biol Chem 2005; 280: 14628-35.
16. Kurlender L, Yousef GM, Memari N, et al. Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancer. Tumour Biol 2004; 25: 149-56.
17. Diamandis EP, Borgono CA, Scorilas A, et al. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis. Tumour Biol 2003; 24: 299-309.
18. Ellis GL, Auclair PL. Atlas of Tumor Pathology: Tumors of the Salivary Glands. Washington, D.C.: Armed Forces Institute of Pathology 1996; 39-56; 155-228.
19. Black MH, Magklara A, Obiezu CV, Melegos DN, Diamandis EP. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen. Clin Chem 1999; 45: 790-9.
20. Yousef GM, Polymeris ME, Grass L, et al. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Res 2003; 63: 3958-65.
21. Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Nat Cancer Inst 1993; 85: 200-6.
22. Tuck AB, O'Malley FP, Singhal H, et al. Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer 1998; 79: 502-8.
23. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-16.
24. Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP. Human kallikrein 6 expression in salivary gland tumors. J Histochem Cytochem 2006; 54: 337-42.
25. Darling MR, Jackson-Boeters L, Daley TD, Diamandis EP. Human kallikrein 13 expression in salivary gland tumors. Int J Biol Markers 2006; 21: 106-10.
26. Magklara A, Scorilas A, Katsaros D, et al. The human KLK8 (neuropsin/ ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res 2001; 7: 806-11.
27. Kishi T, Grass L, Soosaipillai A, et al. Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res 2003; 63: 2771-4.
28. Yousef GM, Obiezu CV, Jung K, Stephan C, Scorilas A, Diamandis EP. Differential expression of kallikrein gene 5 in cancerous and normal testicular tissues. Urology 2002; 60: 714-8.
29. Yousef GM, Scorilas A, Chang A, et al. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues. Prostate 2002; 51: 126-32.
30. Kim H, Scorilas A, Katsaros D, et al. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer 2001; 84: 643-50.
31. Yousef GM, Scorilas A, Kyriakopoulou LG, et al. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin Chem 2002; 48: 1241-50.
32. Brattsand M, Egelrud T. Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem 1999; 274: 30033-40.
33. Brattsand M, Stefansson K, Lundh C, Haasum Y, Egelrud T. A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 2005; 124: 198-203.